(S,S)-GSK321

• CAT Number: I042666
• CAS Number: 1816272-20-4
• Molecular Formula: C28H28FN5O3
• Molecular Weight: 501.55
• Purity: ≥95%
• Synonyms: (7S)-1-[(4-fluorophenyl)methyl]-N-[3-[(1S)-1-hydroxyethyl]phenyl]-7-methyl-5-(1H-pyrrole-2-carbonyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide
• InChI: InChI=1S/C28H28FN5O3/c1-17-14-33(28(37)24-7-4-12-30-24)16-23-25(27(36)31-22-6-3-5-20(13-22)18(2)35)32-34(26(17)23)15-19-8-10-21(29)11-9-19/h3-13,17-18,30,35H,14-16H2,1-2H3,(H,31,36)/t17-,18-/m0/s1
• InChIKey: IVFDDVKCCBDPQZ-ROUUACIJSA-N
• SMILES: C[C@H]1CN(CC2=C1N(N=C2C(=O)NC3=CC=CC(=C3)[C@H](C)O)CC4=CC=C(C=C4)F)C(=O)C5=CC=CN5

(S,S)-GSK321（Cat No.:I042666）is a selective small molecule inhibitor that targets specific enzymes or signaling pathways involved in the regulation of cell growth, survival, and apoptosis. It is particularly studied for its potential therapeutic applications in cancer treatment, where dysregulated cell signaling contributes to tumor progression. By inhibiting these pathways, (S,S)-GSK321 aims to reduce tumor cell proliferation and enhance the effectiveness of targeted therapies. Researchers are exploring its role in modulating key molecular targets, with the goal of improving treatment outcomes in various malignancies and overcoming resistance mechanisms in cancer cells.